Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Vrablík

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Physiological Research|December 19, 2015
Treatment of hypertriglyceridemia: a review of current optionsM Vrablík, R Češka
Casopis Lekaru Ceskych|April 14, 2004
[Changes in the lipid spectrum in hormone replacement therapy]T Fait, M Vrablík
Vnitrni Lekarstvi|June 21, 2007
[Genetics of dyslipidemia--yesterday, today, and tomorrow]J A Hubácek, M Vrablík
Vnitrni Lekarstvi|June 21, 2007
[Lipoprotein (a)]L Zlatohlávek, K Zídková, M Vrablík
Physiological Research|September 12, 2001
Major apolipoprotein B-100 mutations in lipoprotein metabolism and atherosclerosisM Vrablík, R Ceska, A Horínek
Vnitrni Lekarstvi|April 19, 2011
[Dyslipidemia and obesity 2011. Similarities and differences]R Ceska, M Vrablík, P Sucharda
Physiological Research|September 13, 2000
Familial defective apolipoprotein B-100: a lesson from homozygous and heterozygous patientsR Ceska, M Vrablík, A Horínek
Casopis Lekaru Ceskych|December 12, 2007
[Changes of plasminogen activator inhibitor (PAI-1) during estrogen replacement therapy]Z Zizka, T Fait, M Vrablík
Vnitrni Lekarstvi|January 15, 2009
[The Atractiv project: improvement of cardiovascular preventive in primary care in the Czech Republic]M Vrablík, T Freiberger, V Lánská, et al.
Casopis Lekaru Ceskych|August 23, 2006
[Changes in C-reactive protein levels induced by different application forms of estrogen replacement therapy]T Fait, M Vrablík, M Kostírová, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Physiological Research|December 19, 2015
Treatment of hypertriglyceridemia: a review of current optionsM Vrablík, R Češka
Casopis Lekaru Ceskych|April 14, 2004
[Changes in the lipid spectrum in hormone replacement therapy]T Fait, M Vrablík
Vnitrni Lekarstvi|June 21, 2007
[Genetics of dyslipidemia--yesterday, today, and tomorrow]J A Hubácek, M Vrablík
Vnitrni Lekarstvi|June 21, 2007
[Lipoprotein (a)]L Zlatohlávek, K Zídková, M Vrablík
Physiological Research|September 12, 2001
Major apolipoprotein B-100 mutations in lipoprotein metabolism and atherosclerosisM Vrablík, R Ceska, A Horínek
Vnitrni Lekarstvi|April 19, 2011
[Dyslipidemia and obesity 2011. Similarities and differences]R Ceska, M Vrablík, P Sucharda
Physiological Research|September 13, 2000
Familial defective apolipoprotein B-100: a lesson from homozygous and heterozygous patientsR Ceska, M Vrablík, A Horínek
Casopis Lekaru Ceskych|December 12, 2007
[Changes of plasminogen activator inhibitor (PAI-1) during estrogen replacement therapy]Z Zizka, T Fait, M Vrablík
Vnitrni Lekarstvi|January 15, 2009
[The Atractiv project: improvement of cardiovascular preventive in primary care in the Czech Republic]M Vrablík, T Freiberger, V Lánská, et al.
Casopis Lekaru Ceskych|August 23, 2006
[Changes in C-reactive protein levels induced by different application forms of estrogen replacement therapy]T Fait, M Vrablík, M Kostírová, et al.
Pageof 4